TLSI TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. (TLSI) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: May 15, 2026 , by Szela Mary T .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Marshak Richard | Chief Commercial Officer | Sell | 325 | $4.39 | $1.4K | 127,994 −0.3% of holding | |
| Stevens Jennifer | Chief Regulatory Officer | Sell | 316 | $4.39 | $1.4K | 123,794 −0.3% of holding | |
| Cox Bryan F. | Chief of Research | Sell | 296 | $4.39 | $1.3K | 162,805 −0.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.